BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30723247)

  • 1. Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing.
    Zhang X; Wu L; Xu R; Zhu C; Ma G; Zhang C; Liu X; Zhao H; Miao Q
    Sci Rep; 2019 Feb; 9(1):1442. PubMed ID: 30723247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
    Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
    Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinicopathologic characterization of intravenous leiomyomatosis.
    Ordulu Z; Chai H; Peng G; McDonald AG; De Nictolis M; Garcia-Fernandez E; Hardisson D; Prat J; Li P; Hui P; Oliva E; Buza N
    Mod Pathol; 2020 Sep; 33(9):1844-1860. PubMed ID: 32341498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
    Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
    Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of myosin is associated with the development of uterine myoma.
    Zhang W; Cheng Z; Qu X; Dai H; Ke X; Chen Z
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2051-7. PubMed ID: 25181625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.
    Quade BJ; Dal Cin P; Neskey DM; Weremowicz S; Morton CC
    Mod Pathol; 2002 Mar; 15(3):351-6. PubMed ID: 11904348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hyaluronan and CD44 expressions in intravenous leiomyomatosis.
    Chen MJ; Peng Y; Yang YS; Huang SC; Chow SN; Torng PL
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):322-8. PubMed ID: 15762960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata).
    Rieker RJ; Agaimy A; Moskalev EA; Hebele S; Hein A; Mehlhorn G; Beckmann MW; Hartmann A; Haller F
    Pathology; 2013 Jun; 45(4):388-92. PubMed ID: 23635816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous leiomyomatosis of the uterus].
    Banaczek Z; Woźniak M; Grzeszczyk J
    Ginekol Pol; 2003 Feb; 74(2):159-61. PubMed ID: 12715427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous leiomyomatosis: molecular analysis of 17 cases.
    Lu B; Liu Q; Tang L; Ma Y; Shi H
    Pathology; 2020 Feb; 52(2):213-217. PubMed ID: 31889549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.
    Barnaś E; Skręt-Magierło JE; Paszek S; Kaznowska E; Potocka N; Skręt A; Sakowicz A; Zawlik I
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel serum protein biomarkers in the context of 3P medicine for intravenous leiomyomatosis: a data-independent acquisition mass spectrometry-based proteomics study.
    Ge Z; Feng P; Zhang Z; Liang Z; Chen R; Li J
    EPMA J; 2023 Dec; 14(4):613-629. PubMed ID: 38094583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous leiomyomatosis of the uterus: A clinicopathologic analysis of 13 cases with an emphasis on histogenesis.
    Tang L; Lu B
    Pathol Res Pract; 2018 Jun; 214(6):871-875. PubMed ID: 29699902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different clinical diagnosis end up in the same pathological diagnosis of intravascular leiomyomatosis: Two case reports.
    Tan Y; Han J; Wang Z; Yan J; Dong L; Liu R
    Medicine (Baltimore); 2024 Jan; 103(2):e36887. PubMed ID: 38215104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of intravenous leiomyomatosis with high levels of hyaluronan.
    Yaguchi C; Oi H; Kobayashi H; Miura K; Kanayama N
    J Obstet Gynaecol Res; 2010 Apr; 36(2):454-8. PubMed ID: 20492407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24).
    Dal Cin P; Quade BJ; Neskey DM; Kleinman MS; Weremowicz S; Morton CC
    Genes Chromosomes Cancer; 2003 Feb; 36(2):205-6. PubMed ID: 12508249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of uterine leiomyoma with intravenous leiomyomatosis--histological investigation of the pathological condition--.
    Fukuyama A; Yokoyama Y; Futagami M; Shigeto T; Wada R; Mizunuma H
    Pathol Oncol Res; 2011 Mar; 17(1):171-4. PubMed ID: 20383619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center.
    Carr RJ; Hui P; Buza N
    Int J Gynecol Pathol; 2015 Mar; 34(2):169-76. PubMed ID: 25675187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.